Austin TX 前列腺癌临床试验
14项针对 前列腺癌的研究正在 Austin及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
WATER IV PCa (AS Sub-study)
招募中
- Midtown Urology, Austin
- Urology Austin, Austin
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
招募中4 期
- Urology Austin, Austin
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- NEXT Oncology, Austin
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 135, Austin
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Texas Oncology - Central/South Texas ( Site 8003), Austin
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
招募中3 期
- Research Site, Austin
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Urology Austin, Lakeway · 距离 16 英里
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Austin
- Research Site, Austin
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- New Experimental Therapeutics - NEXT Oncology, Austin
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
招募中
- Urology Austin, Austin
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
招募中3 期
- Urology Austin, PLLC - Research Department, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Austin, TX 78758
Sample Collection for Ongoing Research and Product Evaluation Study
招募中观察性研究
- Natera, Inc., Austin
其他城市的 前列腺癌试验
- New York City, NY101 项研究
- Houston, TX73 项研究
- Los Angeles, CA64 项研究
- Boston, MA56 项研究
- Seattle, WA45 项研究
- St. Louis, MO45 项研究
- Chicago, IL45 项研究
- Baltimore, MD45 项研究
- San Francisco, CA44 项研究
- Philadelphia, PA41 项研究
- Nashville, TN40 项研究
- Washington, DC39 项研究
Austin的其他研究
- 非小细胞肺癌29 项研究
- 癌症（所有类型）22 项研究
- 肥胖症22 项研究
- 超重19 项研究
- 转移性癌症18 项研究
- 结直肠癌17 项研究
- 卵巢癌17 项研究
- 心力衰竭17 项研究
- 子宫内膜癌15 项研究
- 乳腺癌15 项研究
- 2型糖尿病14 项研究
- 脂肪性肝病13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。